Subcutaneous ports in the radiology suite: An effective and safe procedure for care in cancer patients

被引:32
作者
deGregorio, MA
Miguelena, JM
Fernandez, JA
deGregorio, C
Tres, A
Alfonso, ER
机构
[1] HOSP CLIN UNIV, DEPT INTERVENT RADIOL, ZARAGOZA 50009, SPAIN
[2] HOSP CLIN UNIV, DEPT SURG, ZARAGOZA 50009, SPAIN
[3] HOSP CLIN UNIV, DEPT ONCOL, ZARAGOZA 50009, SPAIN
关键词
subcutaneous port; reservoir; port systems; central venous access; radiology suite; care in cancer patients; long-term venous access; port catheters; central venous catheters; chemotherapy;
D O I
10.1007/BF00187683
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of the study is to present our experience and compare the results of the three types of ports used as a central venous access and performed in the radiology suite. Between March 1989 and November 1993 we performed 288 implantations (100 Implantofix Seldinger, 100 plastic Hickman port, and 88 stainless steel Port-a-cath) for chemotherapeutic treatment on the same number of patients diagnosed as having cancer. In all cases access was obtained via a subclavian vein (the left one in 185 cases and the right one in 103). All the system ports were implanted in the radiology suite. In all cases the procedure was successfully performed. Complications occurred in 26.3% of cases, most notably thrombosis in 13 cases (4.5%) and infection in 12 cases (4.1%). Duration of the port systems placement varied between 17 and 1467 days (a mean of 315 days). A total of 133 systems have been removed to date, 80(60%) due to termination of chemotherapy, and 53(40%) for treatment of complications. Significant differences (complications and port duration time) were not observed between the three types of reservoir used. Subcutaneous ports are safe, comfortable, and effective devices for central venous access.
引用
收藏
页码:748 / 752
页数:5
相关论文
共 30 条
[1]   VERY LOW-DOSES OF WARFARIN CAN PREVENT THROMBOSIS IN CENTRAL VENOUS CATHETERS - A RANDOMIZED PROSPECTIVE TRIAL [J].
BERN, MM ;
LOKICH, JJ ;
WALLACH, SR ;
BOTHE, A ;
BENOTTI, PN ;
ARKIN, CF ;
GRECO, FA ;
HUBERMAN, M ;
MOORE, C .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :423-428
[2]   IMPLANTABLE CENTRAL VENOUS ACCESS SYSTEM [J].
BOTHE, A ;
PICCIONE, W ;
AMBROSINO, JJ ;
BENOTTI, PN ;
LOKICH, JJ .
AMERICAN JOURNAL OF SURGERY, 1984, 147 (04) :565-569
[3]  
BROTHERS TE, 1988, SURG GYNECOL OBSTET, V166, P295
[4]  
BROVIAC JW, 1973, SURG GYNECOL OBSTET, V136, P602
[5]   INFECTIONS RELATED TO CENTRAL VENOUS CATHETERS [J].
CORONA, ML ;
PETERS, SG ;
NARR, BJ ;
THOMPSON, RL .
MAYO CLINIC PROCEEDINGS, 1990, 65 (07) :979-986
[6]  
DAVIS SJ, 1984, AM SURGEON, V50, P673
[7]   PLACEMENT AND MANAGEMENT OF LONG-TERM CENTRAL VENOUS ACCESS CATHETERS AND PORTS [J].
DENNY, DF .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1993, 161 (02) :385-393
[8]   LOCAL INFUSION OF UROKINASE FOR THE LYSIS OF THROMBOSIS ASSOCIATED WITH PERMANENT CENTRAL VENOUS CATHETERS IN CANCER-PATIENTS [J].
FRASCHINI, G ;
JADEJA, J ;
LAWSON, M ;
HOLMES, FA ;
CARRASCO, HC ;
WALLACE, S .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) :672-678
[9]   TOTALLY IMPLANTED SYSTEM FOR INTRAVENOUS CHEMOTHERAPY IN PATIENTS WITH CANCER [J].
GYVES, J ;
ENSMINGER, W ;
NIEDERHUBER, J ;
LIEPMAN, M ;
COZZI, E ;
DOAN, K ;
DAKHIL, S ;
WHEELER, R .
AMERICAN JOURNAL OF MEDICINE, 1982, 73 (06) :841-845
[10]  
HAIRE WD, 1990, CANCER, V66, P2279, DOI 10.1002/1097-0142(19901201)66:11<2279::AID-CNCR2820661105>3.0.CO